Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells.

Saved in:
Bibliographic Details
Title: Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells.
Authors: Gruijs M; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., Braster R; Genmab, Uppsalalaan 15, Utrecht, Netherlands., Overdijk MB; Genmab, Uppsalalaan 15, Utrecht, Netherlands., Hellingman T; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., Verploegen S; Genmab, Uppsalalaan 15, Utrecht, Netherlands., Korthouwer R; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., van der Wilk BJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., Parren PWHI; Leiden University Medical Center, Department of Immunohematology and Blood Transfusion, Albinusdreef 2, Leiden, Netherlands.; Lava Therapeutics, Yalelaan 60, Utrecht, Netherlands., van der Vliet HJ; Lava Therapeutics, Yalelaan 60, Utrecht, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., Bögels M; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands., van Egmond M; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam-Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Surgery, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands.
Source: Journal of oncology [J Oncol] 2022 Jan 07; Vol. 2022, pp. 3577928. Date of Electronic Publication: 2022 Jan 07 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101496537 Publication Model: eCollection Cited Medium: Print ISSN: 1687-8450 (Print) Linking ISSN: 16878450 NLM ISO Abbreviation: J Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1687-8450
DOI:10.1155/2022/3577928